| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/12/2023 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 87.7k | $0.00 | $0 | | 03/12/2023 |
| 03/03/2023 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 229.4k | $0.00 | $0 | | 03/03/2023 |
| 03/03/2023 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 45.3k | $0.00 | $0 | | 03/03/2023 |
| 03/03/2023 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Performance-Based Restricted Stock Units | 458.7k | $0.00 | $0 | | 03/03/2023 |
| 03/12/2022 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 87.7k | $0.00 | $0 | | 03/12/2022 |
| 03/03/2022 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 181.2k | $0.00 | $0 | | 03/01/2022 |
| 03/03/2022 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Performance-Based Restricted Stock Units | 362.3k | $0.00 | $0 | | 03/01/2022 |
| 03/01/2022 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 36.2k | $0.00 | $0 | | 03/01/2022 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 116.4k | $3.58 | $416.6k | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 102k | $4.44 | $453.1k | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 100k | $2.29 | $229k | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 50k | $3.35 | $167.5k | | 11/09/2021 |
| 11/09/2021 | Kadmon Holdings, Inc. | KDMN | Disposition | Stock Option (right to buy) | 50k | $4.12 | $206k | | 11/09/2021 |
| 05/12/2021 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 116.4k | $3.58 | $416.6k | | 05/12/2021 |
| 03/12/2021 | Amneal Pharmaceuticals, Inc. | AMRX | Exercise | Restricted Stock Units | 87.7k | $0.00 | $0 | | 03/12/2021 |
| 03/01/2021 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 144.8k | $0.00 | $0 | | 03/01/2021 |
| 03/01/2021 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Performance-Based Restricted Stock Units | 289.6k | $0.00 | $0 | | 03/01/2021 |
| 05/13/2020 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 102k | $4.44 | $453.1k | | 05/13/2020 |
| 03/12/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Restricted Stock Units | 350.9k | $0.00 | $0 | | 03/12/2020 |
| 03/12/2020 | Amneal Pharmaceuticals, Inc. | AMRX | Grant | Performance-Based Restricted Stock Units | 701.8k | $0.00 | $0 | | 03/12/2020 |
| 05/15/2019 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 100k | $2.29 | $229k | | 05/15/2019 |
| 07/27/2018 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 50k | $3.35 | $167.5k | | 07/27/2018 |
| 06/29/2017 | Kadmon Holdings, Inc. | KDMN | Grant | Stock Option (right to buy) | 50k | $4.12 | $206k | | 06/29/2017 |
| 06/05/2013 | DELCATH SYSTEMS, INC. | DCTH | Grant | Common Stock | 33k | $0.00 | $0 | | 06/05/2013 |
| 07/06/2012 | DELCATH SYSTEMS, INC. | DCTH | Grant | Stock Option (right to buy) | 54.6k | $2.00 | $109.2k | | 07/06/2012 |
| 03/16/2011 | DUN & BRADSTREET CORP/NW | DNB | Payment of Exercise | Common Stock | 7 | $80.45 | $563.2 | | 03/16/2011 |
| 03/16/2011 | DUN & BRADSTREET CORP/NW | DNB | Grant | Common Stock | 18.291 | $77.57 | $1.4k | | 03/16/2011 |
| 03/04/2011 | DUN & BRADSTREET CORP/NW | DNB | Payment of Exercise | Common Stock | 446 | $80.11 | $35.7k | | 03/04/2011 |
| 06/16/2010 | DUN & BRADSTREET CORP/NW | DNB | Grant | Common Stock | 18.5792 | $73.20 | $1.4k | | 06/16/2010 |
| 02/23/2010 | DUN & BRADSTREET CORP/NW | DNB | Payment of Exercise | Common Stock | 564 | $70.62 | $39.8k | | 02/22/2010 |
| 02/22/2010 | DUN & BRADSTREET CORP/NW | DNB | Payment of Exercise | Common Stock | 469 | $71.23 | $33.4k | | 02/22/2010 |
| 02/11/2010 | DUN & BRADSTREET CORP/NW | DNB | Grant | Non-Qualified Stock Option - right to buy | 19.6k | $70.54 | $1.4M | | 02/11/2010 |